Profil
Andrew Obenshain currently works at Inventiva SA, as Chief Executive Officer & Director from 2025, bluebird bio (UK) Ltd., as Director from 2017, and Biotechnology Innovation Organization, as Director.
Mr. Obenshain also formerly worked at bluebird bio, Inc., as President, Chief Executive Officer & Director from 2021 to 2025 and Shire Pharmaceuticals, Inc., as General Manager-France & Benelux from 2015 to 2016.
Mr. Obenshain received his undergraduate degree from Dartmouth College and Masters Business Admin degree from Kellogg School of Management.
Aktiva positioner av Andrew Obenshain
| Företag | Position | Start |
|---|---|---|
| INVENTIVA | Verkställande Direktör | 2025-10-01 |
bluebird bio (UK) Ltd.
bluebird bio (UK) Ltd. BiotechnologyHealth Technology Engages in research and development on biotechnology | Direktör/Styrelseledamot | 2017-03-30 |
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology advocacy organization representing biotech companies, industry leaders and state biotech associations | Direktör/Styrelseledamot | - |
Tidigare kända positioner av Andrew Obenshain
| Företag | Position | Slut |
|---|---|---|
| GENETIX BIOTHERAPEUTICS, INC. | Verkställande Direktör | 2025-06-02 |
Shire Pharmaceuticals, Inc.
Shire Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Företagsledare/Principal | 2016-09-01 |
Andrew Obenshains utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 7 |
|---|---|
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology advocacy organization representing biotech companies, industry leaders and state biotech associations | Commercial Services |
Dartmouth College
Dartmouth College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
bluebird bio, Inc.
bluebird bio, Inc. BiotechnologyHealth Technology Develops genetic therapies based on blood stem cells | Health Technology |
Shire Pharmaceuticals, Inc.
Shire Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Kellogg School of Management
Kellogg School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Inventiva SA
Inventiva SA BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops oral small molecule therapies for the treatment of MASH and other diseases | Health Technology |
bluebird bio (UK) Ltd.
bluebird bio (UK) Ltd. BiotechnologyHealth Technology Engages in research and development on biotechnology | Health Technology |
















